treatment effect of peripheral blood stem cells in repair of fractures

Evaluation of the therapeutic effects of using peripheral blood stem cells in spinal fusion in patients with thoracolumbar fractures

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100407003647N2

Enrollment

Registered

2019-10-13

Start date

2017-09-19

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracolumbar fracture fusion.

Interventions

Intervention group: Uses of Mesenchymal cell derived from peripheral blood.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: age 20-60 years GCS:12-15 spine surgery is needed

Exclusion criteria

Exclusion criteria: HIV+,HBV+,HCV+ pregnancy Probability of patient not following Previous bone malignancy Pelvic fracture Background illnesses including osteoporosis Taking steroids

Design outcomes

Primary

Measure	Time frame
Evaluation of bone fracture fusion of spinal CT scan with fine cats based on Glassman grading. Timepoint: 12 months after spinal surgery. Method of measurement: Interpretation of CT scan with subtle cats of the spine performed by the surgeon.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohammadreza ehsaee

Mashhad University of Medical Sciences

ehsaeemr@mums.ac.ir+98 51 3802 6441

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026